Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mick Matthew J"'
Publikováno v:
Journal of Geriatric Medicine and Gerontology. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98659278276c436136b0627595cfef14
https://doi.org/10.23937/2469-5858/1510110
https://doi.org/10.23937/2469-5858/1510110
Autor:
Pinski, Sergio L., Mick, Matthew J., Arnold, Anita Z., Golding, Leonard, McCarthy, Patrick M., Castle, Lon W., Maloney, James D., Trohman, Richard G.
Publikováno v:
Pacing & Clinical Electrophysiology; Jul1991, Vol. 14 Issue 7, p1138-1147, 10p, 1 Diagram, 3 Charts
Publikováno v:
Journal of the American Society of Echocardiography; September-October 1990, Vol. 3 Issue: 5 p412-415, 4p
Publikováno v:
Journal of the American College of Cardiology; July 1994, Vol. 24 Issue: 1 p74-80, 7p
Autor:
Arnold, Anita Zeiler, Mick, Matthew J., Mazurek, Robert P., Loop, Floyd D., Trohman, Richard G.
Publikováno v:
Journal of the American College of Cardiology; March 1992, Vol. 19 Issue: 4 p851-855, 5p
Autor:
Hall, Jack J., Arnold, Anita M., Valentine, Russell P., McCready, Robert A., Mick, Matthew J.
Publikováno v:
In The American Journal of Cardiology 1996 77(1):108-109
Autor:
Matthew J. Riese, Lynn M. Schuchter, E. John Wherry, Drew A. Torigian, Richman P. Lee, Martha Sweeney, Rosemarie Mick, Ravi K. Amaravadi, Xiaowei Xu, David L. Bajor, Erietta Stelekati, Brendan J. Sullivan, Robert H. Vonderheide
Publikováno v:
Cancer Immunology Research. 3:A38-A38
Purpose: Combining therapeutic activation of immune cells and checkpoint inhibition may improve response rates and overall survival in patients with metastatic melanoma. CP-870,893 (αCD40) is an agonistic fully human IgG2 mAb targeting the immune st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94f854e0a325f0a7c54805ab8c6d0515
https://doi.org/10.1158/2326-6074.tumimm14-a38
https://doi.org/10.1158/2326-6074.tumimm14-a38
Autor:
Martha Sweeney, Robert H. Vonderheide, Brendan J. Sullivan, Ravi K. Amaravadi, Rosemarie Mick, Xiaowei Xu, Erietta Stelekati, Drew A. Torigian, Lee P. Richman, Lynn M. Schuchter, E. John Wherry, Matthew J. Riese, David L. Bajor
Publikováno v:
Cancer Research. 75:CT137-CT137
Purpose: Combining immunostimulatory monoclonal (mAb) and checkpoint inhibition may improve response rates and overall survival in patients with metastatic melanoma. CP-870,893 is an agonistic fully human IgG2 mAb targeting the immune stimulatory mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9cf019a890053b417715439ac4a4430
https://doi.org/10.1158/1538-7445.am2015-ct137
https://doi.org/10.1158/1538-7445.am2015-ct137